Simultaneous presentation of low-and middle-income countries data for hematologic cancers: a welcome step towards equity

Advances in cancer treatment over the last few decades have been nothing short of remarkable, and led to significant improvements survival quality life.This has possible with several noticeable changes such as discovery molecular mechanisms cancer, targeted drug development, better laboratory methods. However, a majority this benefit is confined high income countries (HICs), international disparities are still widely prevalent.<sup> </sup>Several unique socioeconomic, environmental political challenges preclude emulation new developments LMIC (low-and middle-income countries) settings.